Guidelines for the prevention of sepsis in asplenic and hyposplenic patients

Internal Medicine Journal

Volumn 38, Issue 5, 2008, Pages 349-356

  Spelman, D ^a   Buttery, J ^b   Daley, A ^c   Isaacs, D ^f,g   Jennens, I ^d   Kakakios, A ^g   Lawrence, R ^h   Roberts, S ^l   Torda, A ⁱ   Watson, D A R ^j   Woolley, I ^a,e   Anderson, T ^k   Street, A ^a  

^a ALFRED HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e MONASH MEDICAL CENTRE   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^h SYDNEY ADVENTIST HOSPITAL   (Australia)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

^j CANBERRA HOSPITAL   (Australia)

^k ROYAL HOBART HOSPITAL   (Australia)

^l AUCKLAND CITY HOSPITAL   (New Zealand)

more..

Author keywords

Antibiotics; Asplenia; Hyposplenia; Immunization; Spleen

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; CEFUROXIME; COTRIMOXAZOLE; ERYTHROMYCIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; MOXIFLOXACIN; PENICILLIN V; PNEUMOCOCCUS VACCINE; ROXITHROMYCIN;

ANTIBIOTIC PROPHYLAXIS; ASPLENIA; AUSTRALIA; BITE; HUMAN; IMMUNIZATION; INFECTION PREVENTION; MORTALITY; NEW ZEALAND; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEPSIS; TRAVEL;

ANIMALS; HUMANS; PRACTICE GUIDELINES AS TOPIC; SEPSIS; SPLENECTOMY; SPLENIC DISEASES;

EID: 42049095732     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01579.x     Document Type: Review

References (57)

1. de Montalembert M, Lenoir G. Antibiotic prevention of pneumococcal infections in asplenic hosts: admission of insufficiency. Ann Hematol 2004 83 : 18 21.
2. Waghorn DJ. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol 2001 54 : 214 18.
3. Working party of the British Committee for Standards in Haematology, Clinical Haematology Task Force. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. BMJ 1996 312 : 430 34.
4. Davies JM, Barnes R, Milligan D. Working Party of the Haematology/Oncology Taskforce for the British Committee for Standards in Haematology. Update of guidelines for the prevention and treatment of infections in patients with an absent or dysfunctional spleen. Clin Med 2002 2 : 440 43.
5. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. Prevention and therapy of bacterial infections for children with asplenia and hyposplenia. Paediatr Child Health 1999 4 : 417 21.
6. Antibiotic Expert Group. Postsplenectomy prophylaxis. Therapeutic Guidelines: Antibiotic, Version 13. North Melbourne. Therapeutics Guideline Ltd. 2006 181 2.
7. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mort Wkly Rep 1997 46 : 11.
8. Splenic disorders. In : Immunization of Immunocompromised Persons. Canadian Immunization Guidelines, 7th edn. 2006 119 21.
9. Ministry of Health. Immunisation Handbook 2006. Ministry of Health, Wellington, New Zealand, 2006.
10. EI-Alfy M, El-Sayed M. Overwhelming post-splenectomy infection: is quality of patient knowledge enough for prevention? Haematol J 2004 5 : 77 80.
11. Watkins EJ, Brooksby, Schweiger MS, Enright SM. Septicemia in a pig-farm worker. Lancet 2001 357 : 38.
12. Rosner F, Zarrabi MH, Benach JL, Habicht GS. Babesiosis in splenectomized adults. Review of 22 reported cases. Am J Med 1984 76 : 696 701.
13. Boone K, Watters D. The incidence of malaria after splenectomy in Papua New Guinea. BMJ 1995 311 : 1273.
14. Rabinstein A, Tikhominov V, Kaluta A, Gelfmann N, Iannini P, Edwards L. Recurrent and prolonged fever in asplenic patients with human granulocytic ehrlichiosis. QJM 2000 93 : 198 201.
15. Shepard C, Daneshvar M, Kaiser R, Ashford D, Lonsway D, Patel J et al. Bordetella holmesii bacteremia: a newly recognised clinical entity among asplenic patients. Clin Infect Dis 2004 38 : 799 804.
16. Green JB, Shackford SR, Sise MJ, Fridlund P. Late septic complications in adults following splenectomy for trauma: a prospective analysis of 144 patients. J Trauma: Injury Infect Critical Care 1986 26 : 999 1004.
17. Sarangi J, Coleby M, Trivella M, Reilly S. Prevention of post-splenectomy sepsis: a population based approach. J Public Health Med 1997 19 : 208 12.
18. Brigden M, Preece E. Preventing postsplenectomy sepsis. Can Med Assoc J 1984 130 : 334.
19. Kath S, Panzer S, Kletter K, Minar E, Stain-Kos M, Walter R et al. Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease. Ann Intern Med 1988 109 : 461 4.
20. Corazza GR, Zoli G, Di Sabatino A, Ciccocioppo R, Gasbarrini G. A reassessment of splenic hypofunction in celiac disease. Am J Gastroenterol 1999 94 : 391 7.
21. Adekile AD, Owunwanne A, Al-Za'abi K, Haider MZ, Tuli M, Al-Mohannadi S. Temporal sequence of splenic dysfunction in sickle cell disease. Am J Hematol 2002 69 : 23 7.
22. Vaiopoulos G, Konstantopoulos K, Osterland D. Asplenia in systemic lupus erythematosus: a simple co-incidence? Clin Exp Rheumatol 1995 13 : 513 15.
23. Muller AF, Cornford E, Toghill PJ. Splenic function in inflammatory bowel disease: assessment by differential interference microscopy and splenic ultrasound. QJM 1993 86 : 333 40.
24. Feder H, Pearson H. Assessment of splenic function in familial asplenia. N Engl J Med 1999 341 : 210 12.
25. Resende V, Petroianu A. Functions of the splenic remnant after sub-total splenectomy for the treatment of severe splenic injuries. Am J Surg 2003 185 : 311 15.
26. Kreutzmann S, Rosado M, Weber H, Germing U, Tournilhac O, Peter H et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003 197 : 939 45.
27. Cullingford G, Watkins D, Watts A, Mallon D. Severe late postsplenectomy infection. Br J Surg 1991 78 : 716 21.
28. Schwartz P, Sterioff S, Mucha P, Melton L, Offord P. Postsplenectomy sepsis and mortality in adults. JAMA 1982 248 : 2279 83.
29. Ejstrud P, Kristensen B, Hansen JB, Madsen KM, Schonheyder HC, Sorensen HT. Risk and patterns of bacteremia after splenectomy: a population based study. Scand J Infect Dis 2000 32 : 521 5.
30. Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and death among post-splenectomy patients. J Infect 2001 43 : 182 6.
31. Holdsworth R, Irving A, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991 78 : 1031 38.
32. Walker W. Splenectomy in childhood: a review in England and Wales 1960-4. Br J Surg 1976 63 : 36 43.
33. Waghorn DJ, Maynon-White RT. A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed? J Infect 1997 35 : 289 94.
34. Davidson RN, Wall RA. Prevention and management of infections in patients without a spleen. Clin Microbiol Infect 2001 7 : 657 60.
35. Nottingham University Hospitals. NHS Trust. Guidelines for the Management of Adult Patients with an Absent or Poorly Functioning Spleen. http://www.nuh.nhs.uk 2006.
36. Gaston M, Verter J, Woods G, Pegelow C, Kelleher J, Presbury G et al. Prophylaxis with oral penicillin in children with sickle cell anaemia. A randomized trial. N Engl J Med 1986 314 : 1593 9.
37. Falletta JM, Woods GM, Verter JI, Buchanan GR, Pegelow CH, Iyer RV et al. Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study 11. J Pediatr 1995 127 : 685 90.
38. Klinge J, Hammersen G, Scharf J, Lutticken R, Reinert R. Overwhelming post-splenectomy infection with vaccine-type Streptococcus pneumoniae in a 12-year-old girl despite vaccination and antibiotic prophylaxis. Infection 1997 25 : 368 71.
39. Watson DA. Stand-by treatment of sepsis in people without a spleen. Clin Microbiol Infect 2003 9 : 242.
40. Whitney C, Farley M, Hadler J, Harrison L, Bennett N, Lynfield R et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003 348 : 1737 46.
41. Breukels MA, Zandvoort A, van Den Dobbelsteen GP, van Den Muijsenberg A, Lodewijk ME, Beurret M et al. Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides. Infect Immun 2001 69 : 7853 7.
42. Konradsen H, Henrichsen J. Pneumococcal infections in splenectomised children are preventable. Acta Paediatr Scand 1991 80 : 423 7.
43. Australian Immunisation Handbook, 8th edn. Canberra : NHMRC 2003.
44. Schultze GE, Mason E, Barson W, Kim K, Wald E, Givner L et al. Invasive pneumococcal infections in children with asplenia. Paediatr Infect Dis J 2002 21 : 278 82.
45. Zielen S, Buhring I, Strnad N, Reichenbach J, Hofmann D. Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine. Infect Immun 2000 68 : 1435 40.
46. Shatz D, Romero-Steiner S, Elie C, Holder P, Carlone G. Antibody responses in post-splenectomy trauma patients receiving the 23 valent pneumococcal polysaccharide vaccine at 14 versus 28 days post-operatively. J Trauma 2002 53 : 1037 42.
47. Shatz D, Schinksy M, Pais L, Romero-Steiner S, Kirton O, Carlone G. Immune response of splenectomised trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy. J Trauma 1998 44 : 760 65.
48. Immunisation of the Immunocompromised Child, Best Practice Statement. Royal College of Paediatrics and Child Health, London 2002.
49. Wernette C, Frasch C, Madore D, Carlone G, Goldblatt D, Plikaytis B et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol 2003 10 : 514 19.
50. Rutherford EJ, Livengood J, Higginbotham M, Miles WS, Koestner J, Edwards KM et al. Efficacy and safety of pneumococcal revaccination after splenectomy for trauma. J Trauma 1995 39 : 448 52.
51. Ruben F, Hankins W, Zeigler Z, Norden C, Harrison A, Winklestein A et al. Antibody responses to meningococcal polysaccharide vaccine in adults without a spleen. Am J Med 1984 76 : 115 21.
52. Balmer P, Falconer M, McDonald P, Andrews N, Fuller E, Riley C et al. Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals. Infect Immun 2004 72 : 332 7.
53. Cimaz R, Mensi C, D'Angelo E, Fantola E, Milone V, Biasio L et al. Safety and immunogenicity of a conjugate vaccine against Haemophilus influenzae type b in splenectomised patients with Cooley anemia. J Infect Dis 2001 183 : 1819 21.
54. Li Volti S, Sciotto A, Fisichella M, Sciacca A, Munda D, Mangiagli A et al. Immune responses to the administration of a vaccine against Haemophilus influenzae type b in splenectomised and non-splenectomised patients. J Infect 1999 39 : 38 41.
55. Watson DA. Pre-travel health advice for asplenic individuals. J Travel Med 2003 10 : 117 21.
56. Herwaldt B, Persing D, Precigout E, Goff W, Mathiesen D, Taylor P et al. A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med 1996 124 : 643 50.
57. Spickett GP, Bullimore J, Wallis J, Smith S, Saunders P. Northern region asplenia register - analysis of first two years. J Clin Pathol 1999 52 : 424 9.